CD274 and non-small cell lung carcinoma: Multivariate logistic regression analysis showed that the clinical stage (odds ratio [OR] 1.579, 95% confidence interval [CI] 0.220–0.703, P<0.001) was a significant predictor of different expression statuses of PD-L1 in patients with NSCLC.